Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Angiogenesis and endocrine tumors].

J Dumortier1, C Ratineau, C Roche

  • 1Fédération des spécialités digestives, Unité Inserm 45, Hôpital Edouard-Herriot, 5, place d'Arsonval, 69437 Lyon Cedex 03, France.

Bulletin Du Cancer
|March 6, 1999
PubMed
Summary

Endocrine tumors develop dense blood vessel networks, similar to normal endocrine tissues. Loss of anti-angiogenic factors, not increased pro-angiogenic factors, may initiate tumor blood vessel growth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peri-operative management of obese patients in digestive surgery: Clinical practice guidelines from the French Society of Digestive Surgery.

Journal of visceral surgery·2023
Same author

SARS-CoV-2 Testing and Patient Waiting Times in the Emergency Department.

Irish medical journal·2022
Same author

Corrigendum to "Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 32 (2021) 439-451].

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Comparison of intubating conditions after induction with propofol and remifentanil or sufentanil : Randomized controlled REMIDENT trial for surgical tooth extraction.

Der Anaesthesist·2020
Same author

On first-pass, twitter response is inferior to expectations.

The American journal of emergency medicine·2019

Area of Science:

  • Endocrinology
  • Oncology
  • Vascular Biology

Context:

  • Endocrine tumors exhibit significant hypervascularity, a trait shared with normal endocrine tissues' specialized capillary networks.
  • The precise cellular and molecular mechanisms driving angiogenesis in endocrine tumorigenesis remain largely unelucidated.
  • Normal endocrine cells constitutively express angiogenic factors like VEGF, crucial for tissue vascular architecture.

Purpose:

  • To explore the poorly understood mechanisms of angiogenesis in endocrine tumors.
  • To investigate the roles of angiogenic and anti-angiogenic factors in endocrine tumorigenesis.
  • To identify potential therapeutic targets for endocrine neoplasms.

Summary:

  • While normal endocrine tissues rely on factors like VEGF for vascularization, endocrine tumors may not primarily involve their overexpression.

Related Experiment Videos

  • Emerging evidence suggests that the downregulation of specific endocrine anti-angiogenic factors could be critical for initiating angiogenesis in endocrine hyperplasia, facilitating the transition to neoplasia.
  • Identifying and characterizing these inhibitory factors is a key research objective.

    • Impact:

    • Understanding endocrine tumor angiogenesis can reveal novel therapeutic strategies.
    • This research may lead to treatments targeting the unique vascularization of endocrine neoplasms.
    • Elucidating the role of anti-angiogenic factors could offer new avenues for managing endocrine hyperplasia and neoplasia.